AI|ffinity
AI|ffinity speeds early drug discovery and protein engineering by combining NMR data with AI to identify hits and optimize leads faster. The company integrates ultra-fast 1D ligand-observed and rapid 2D protein-observed NMR with 3D/4D/5D experiments, AI-driven software, and cheminformatics in a lab-in-the-loop NMR-AI platform. This platform reads atomic-level interactions from both ligand and protein perspectives to improve hit identification, structure determination, and hit-to-lead optimization. Customers include pharmaceutical and biotechnology companies, NMR centers, and academic groups, and the offering functions as a TechBio B2B platform that complements existing discovery workflows. By shortening experimental cycles and enriching structural insight, AI|ffinity aims to raise success rates and reduce early discovery costs.
AI|ffinity
AI|ffinity speeds early drug discovery and protein engineering by combining NMR data with AI to identify hits and optimize leads faster. The company integrates ultra-fast 1D ligand-observed and rapid 2D protein-observed NMR with 3D/4D/5D experiments, AI-driven software, and cheminformatics in a lab-in-the-loop NMR-AI platform. This platform reads atomic-level interactions from both ligand and protein perspectives to improve hit identification, structure determination, and hit-to-lead optimization. Customers include pharmaceutical and biotechnology companies, NMR centers, and academic groups, and the offering functions as a TechBio B2B platform that complements existing discovery workflows. By shortening experimental cycles and enriching structural insight, AI|ffinity aims to raise success rates and reduce early discovery costs.